Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.

Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.

<h4>Background</h4>Brazil and Scotland have used mRNA boosters in their respective populations since September 2021, with Omicron's emergence accelerating their booster program. Despite this, both countries have reported substantial recent increases in Coronavirus Disease 2019 (COVI...

Full description

Bibliographic Details
Main Authors: Thiago Cerqueira-Silva, Syed Ahmar Shah, Chris Robertson, Mauro Sanchez, Srinivasa Vittal Katikireddi, Vinicius de Araujo Oliveira, Enny S Paixão, Igor Rudan, Juracy Bertoldo Junior, Gerson O Penna, Neil Pearce, Guilherme Loureiro Werneck, Mauricio L Barreto, Viviane S Boaventura, Aziz Sheikh, Manoel Barral-Netto
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1004156

Internet

https://doi.org/10.1371/journal.pmed.1004156

Similar Items